Skip to content
Nonprofiteer
← ODYLIA THERAPEUTICS INC

Form 990 for tax year 2023

Filed by ODYLIA THERAPEUTICS INC.

Totals

Total revenue
$570,773
Total expenses
$867,236
Contributions and grants received
$289,283
Grants paid
$0
Program service revenue
$241,089
Investment income
$40,401
Other revenue
$0
Total assets, end of year
$9,688,644
Total liabilities, end of year
$41,336
Net assets or fund balances, end of year
$9,647,308
Program services expenses (Part IX)
$636,178
Management and general expenses
$124,704
Fundraising expenses
$106,354
Program service expenses (Part III)
$636,178

Program services were 73.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $289,283

  • 2a · Program service revenue: SERVICE FEE REVENUE

    total $241,089 · related or exempt $241,089

  • 3 · Investment income

    total $40,401 · excluded $40,401

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $230,695 · program services $166,788 · management and general $31,752 · fundraising $32,155

  • 7 · Other salaries and wages

    total $250,506 · program services $181,110 · management and general $34,479 · fundraising $34,917

  • 8 · Pension plan contributions

    total $5,230 · program services $3,781 · management and general $720 · fundraising $729

  • 9 · Other employee benefits

    total $15,338 · program services $11,089 · management and general $2,111 · fundraising $2,138

  • 10 · Payroll taxes

    total $36,113 · program services $26,628 · management and general $4,475 · fundraising $5,010

  • 11c · Fees: accounting

    total $10,939 · management and general $10,939

  • 11g · Fees: other

    total $225,890 · program services $219,953 · management and general $1,848 · fundraising $4,089

  • 12 · Advertising and promotion

    total $59,712 · program services $20,709 · management and general $20,486 · fundraising $18,517

  • 13 · Office expenses

    total $5,218 · program services $110 · management and general $5,048 · fundraising $60

  • 14 · Information technology

    total $4,861 · management and general $2,952 · fundraising $1,909

  • 17 · Travel

    total $11,150 · program services $4,343 · management and general $5,560 · fundraising $1,247

  • 19 · Conferences, conventions and meetings

    total $11,584 · program services $1,667 · management and general $4,334 · fundraising $5,583

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $148,526 · end of year $108,152

  • 2 · Savings and temporary cash investments

    end of year $64,034

  • 3 · Pledges and grants receivable

    end of year $14,000

  • 9 · Prepaid expenses and deferred charges

    beginning of year $3,515 · end of year $3,515

  • 11 · Investments: publicly traded securities

    beginning of year $1,119,610 · end of year $748,943

  • 14 · Intangible assets

    beginning of year $8,750,000 · end of year $8,750,000

  • 17 · Accounts payable and accrued expenses

    beginning of year $95,757 · end of year $41,336

  • 27 · Net assets without donor restrictions

    beginning of year $9,925,894 · end of year $9,647,308

Mission and programs · 2023

Mission

ODLYIA'S MISSION IS TO FACILITATE THE RESEARCH OF GENETICS, GENETIC THERAPIES AND SAFE AND EFFECTIVE TREATMENTS THAT ADDRESS RARE AND ULTRA-ARE DISEASES, INCLUDING TO (I) RESEARCH AND DEVELOP METHODOLOGIES FOR MORE EFFECTIVE AND EFFICIENT DEVELOPMENT OF THERAPIES AND TREATMENTS OF RARE AND ULTRA-RARE DISEASES INCLUDING, BUT NOT LIMITED TO, THE CONDUCT AND OVERSIGHT OF CLINICAL TRIALS, (II) COMPILE AND DISSEMINATE SCIENTIFIC LITERATURE THAT PROMOTES AND ATTRACTS RESOURCES FOR RESEARCH AND THE DEVELOPMENT OF THERAPIES AND TREATMENTS THAT ADDRESS RARE AND ULTRA-RARE DISEASES, (III) DEVELOP BEST PRACTICES IN THE FIELD OF RESEARCH AND THE DEVELOPMENT OF TREATMENTS OF RARE AND ULTRA-RARE DISEASES AND (IV) ENGAGE IN AND CARRY ON ANY SUCH OTHER ACTIVITIES IN FURTHERANCE OF SUCH PURPOSES AS NONPROFIT CORPORATIONS ORGANIZED UNDER THE DELAWARE GENERAL CORPORATION LAW MAY CONDUCT, BUT ONLY TO THE EXTENT THAT SUCH ACTIVITIES SHALL BE PERMITTED UNDER SECTION 50L(C)(3) OF THE CODE.

Activities or mission (Part I)

ODLYIA UTILIZES A UNIQUE, NON-PROFIT MODEL TO ACCELERATE THE DEVELOPMENT OF GENE THERAPIES FROM PEOPLE WITH RARE DISEASE, CHANGING THE WAY TREATMENTS ARE BROUGHT FROM THE LAB TO THE CLINIC.

  • ADVANCING DRUG DEVELOPMENT FOR RARE DISEASES. ODYLIA'S TOP THREE PROGRAMS ARE RPGRIP1, USH1C, AND BRYDGE SOLUTIONS.

    Expenses $636,178 · Revenue $241,089

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Ashley Winslow

    CEO/CSO

    Total calculated
    $230,695
    From this org
    $230,695
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $230,695
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $230,695
  • Jenny Klein

    MANAGER OF OPERATIONS & PROGRAM MANAGEMENT

    Total calculated
    $109,099
    From this org
    $109,099
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Scott Dorfman

    BOARD CHAIRMAN/TREASURER

    Total calculated
    $0
    Hours/week
    6
  • Susie Trotochaud

    SECRETARY

    Total calculated
    $0
    Hours/week
    3
  • Khandan Baradaran

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Brian Fenton

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Matthew Pletcher

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Luk Vandenbergh

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Greg Robinson

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2023
Filed
8 November 2024
IRS schema version
2023v5.1
Source object
202433139349303443

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.